350540 <common-name>1-benzofuran-2-ylmethyl n-[(2r)-3-(1h-indol-3-yl)-2-methyl-1-[methyl-[(1s)-1-pyridin-4-ylethyl]amino]-1-oxopropan-2-yl]carbamate</common-name> <description>1-benzofuran-2-ylmethyl n-[(2r)-3-(1h-indol-3-yl)-2-methyl-1-[methyl-[(1s)-1-pyridin-4-ylethyl]amino]-1-oxopropan-2-yl]carbamate is a chemical compound with the formula C30H30N4O4. With an average molecular weight of 510.60 g/mol, 1-benzofuran-2-ylmethyl n-[(2r)-3-(1h-indol-3-yl)-2-methyl-1-[methyl-[(1s)-1-pyridin-4-ylethyl]amino]-1-oxopropan-2-yl]carbamate is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>177372</pubchem-id> <chemical-formula>C30H30N4O4</chemical-formula> <weight>510.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:40:18Z</created-at> <updated-at type="dateTime">2026-08-31T15:40:18Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C1=CC=NC=C1)N(C)C(=O)C(C)(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC5=CC=CC=C5O4</moldb-smiles> <moldb-formula>C30H30N4O4</moldb-formula> <moldb-inchi>InChI=1S/C30H30N4O4/c1-20(21-12-14-31-15-13-21)34(3)28(35)30(2,17-23-18-32-26-10-6-5-9-25(23)26)33-29(36)37-19-24-16-22-8-4-7-11-27(22)38-24/h4-16,18,20,32H,17,19H2,1-3H3,(H,33,36)/t20-,30+/m0/s1</moldb-inchi> <moldb-inchikey>NLTTWNYWDRCTCE-WENCNXQZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">510.2267055</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346433</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>1-benzofuran-2-ylmethyl n-[(2r)-3-(1h-indol-3-yl)-2-methyl-1-[methyl-[(1s)-1-pyridin-4-ylethyl]amino]-1-oxopropan-2-yl]carbamate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Indoles and derivatives</klass> <subklass>Tryptamines and derivatives</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300845</sync-id> <structure-inchikey>NLTTWNYWDRCTCE-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000000800080002100000010000000000000000000000000000000001000000000008000002008002100800000000000000000000000000000800000000000000000000000000000000020800000000100000000001040800000000000030000020000000100104082000000000000000020000100000000000040000040004001800000200080000080100000000100800000004000020000000008000000000004040400080000000000000000000400000000000000000000000000040000001900000000000000000001080000000000000202000001000000801000000001102041000000008400024000000000000000000000000002</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBB0AoAAAAAwMGQGgAAAADAwEG QGgAAAADAwEHACgAAAADAwYAYAAAAAEDBgAoAAAAAwQIACgAAAADAgYAIAAA AAQGAGAAAAABAwYAYAAAAAICBkAoAAAAAwQGQGgAAAADAwEHQDgAAAADAQMG QCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZA KAAAAAMEBwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAggAKAAAAAMCBgBgAAAA AgIGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB BkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQIQCgAAAADAgsAAQABAgACA2gM AwRoDAQFaAwFBmgMBgdoDAEIAAgJAAgKIAoLKAIKDAAMDQAMDgAODwAPEGgM EBFoDBESaAwSE2gMExRoDBQVaAwVFmgMFhdoDAwYABgZIBkaKAIZGyAbHAAc HQAdHmgMHh9oDB8gaAwgIWgMISJoDCIjaAwjJGgMJCVoDAcCaAwXD2gMFxJo DCUdaAwkH2gMQgUAAAAGAwQFBgcCBRAPFxIRBhMUFRYXEgUeHSUkHwYgISIj JB8XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:32Z</structure-indexed-at> </compound>